ChiCTR2200057583 版本V1.2 版本创建时间2022/11/14 10:53:59 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200057583 

最近更新日期:

Date of Last Refreshed on:

2022-11-14 10:51:47 

注册时间:

Date of Registration:

2022-03-15 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

磁刺激对构音障碍的临床疗效研究

Public title:

Clinical effect of magnetic stimulation on dysarthria

注册题目简写:

English Acronym:

研究课题的正式科学名称:

磁刺激对构音障碍的临床疗效研究

Scientific title:

Clinical effect of magnetic stimulation on dysarthria

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

闫志杰 

研究负责人:

闫志杰 

Applicant:

Zhijie Yan 

Study leader:

Zhijie Yan 

申请注册联系人电话:

Applicant telephone:

+86 13938589704

研究负责人电话:

Study leader's
telephone:

+86 13938589704

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yzj2020mail@126.com

研究负责人电子邮件:

Study leader's E-mail:

yzj2020mail@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省新乡市红旗区华兰大道东段599号

研究负责人通讯地址:

河南省新乡市红旗区华兰大道东段599号

Applicant address:

599 Hualan Avenue East, Hongqi District, Xinxiang, Henan

Study leader's address:

599 Hualan Avenue East, Hongqi District, Xinxiang, Henan

申请注册联系人邮政编码:

Applicant postcode:

453003

研究负责人邮政编码:

Study leader's postcode:

453003

申请人所在单位:

新乡医学院第三附属医院

Applicant's institution:

The Third Affiliated Hospital of Xinxiang Medical University

研究负责人所在单位:

新乡医学院第三附属医院

Affiliation of the Leader:

The Third Affiliated Hospital of Xinxiang Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

K2022-014-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

新乡医学院第三附属医院医学研究伦理委员会

Name of the ethic committee:

Ethics Committee of The Third Affiliated Hospital of Xinxiang Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-03-02 00:00:00

伦理委员会联系人:

申芳芳

Contact Name of the ethic committee:

Fangfang Shen

伦理委员会联系地址:

河南省新乡市红旗区华兰大道东段599号

Contact Address of the ethic committee:

599 Hualan Avenue East, Hongqi District, Xinxiang, Henan

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

新乡医学院第三附属医院

Primary sponsor:

The Third Affiliated Hospital of Xinxiang Medical University

研究实施负责(组长)单位地址:

河南省新乡市红旗区华兰大道东段599号

Primary sponsor's address:

599 Hualan Avenue East, Hongqi District, Xinxiang, Henan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南

市(区县):

新乡

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡医学院第三附属医院

具体地址:

河南省新乡市红旗区华兰大道东段599号

Institution
hospital:

The Third Affiliated Hospital of Xinxiang Medical University

Address:

599 Hualan Avenue East, Hongqi District, Xinxiang, Henan

经费或物资来源:

Source(s) of funding:

None

研究疾病:

卒中  

Target disease:

Stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

验证重复周围磁刺激对构音障碍的临床有效性及安全性。  

Objectives of Study:

To verify the clinical efficacy and safety of repetitive peripheral magnetic stimulation on dysarthria.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 病程大于1周;
2. 男女不限;
3. 18-80岁;
4. MOCA≥26;
5. 舌肌运动障碍等构音障碍表现;
6. 无局部金属、心脏起搏器等磁刺激禁忌症;
7. 自愿参与本研究,并签署知情同意书。

Inclusion criteria

1. The course of disease is more than 1 week;
2. Men and women are not limited;
3. 18-80 years old;
4. MOCA>=26;
5. Dysarthria such as dyskinesia of lingual muscle;
6. No contraindications to magnetic stimulation such as local metal and cardiac pacemaker;
7. Voluntarily participate in this study and sign informed consent.

排除标准:

1. 心功能不全、肝肾功能障碍、严重感染、血液系统疾病、癫痫等严重基础疾病;
2. 病情变化或不稳定;
3. 精神或情绪障碍。

Exclusion criteria:

1. Cardiac insufficiency, liver and kidney dysfunction, serious infection, blood system diseases, epilepsy and other serious basic diseases;
2. Change or instability of the disease;
3. Mental or emotional disorders.

研究实施时间:

Study execute time:

From 2022-03-15 00:00:00 To 2023-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-03-15 00:00:00 To 2023-03-01 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

12

Group:

Experimental group

Sample size:

干预措施:

重复周围磁刺激

干预措施代码:

Intervention:

Repetitive peripheral magnetic stimulation

Intervention code:

组别:

对照组

样本量:

12

Group:

Control group

Sample size:

干预措施:

常规训练

干预措施代码:

Intervention:

Routine training

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南 

市(区县):

新乡 

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡医学院第三附属医院 

单位级别:

三级 

Institution
hospital:

The Third Affiliated Hospital of Xinxiang Medical University

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

声学指标

指标类型:

主要指标

Outcome:

Acoustic index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Frenchay构音障碍评定法分级

指标类型:

次要指标

Outcome:

Classification of Frenchay's dysarthria by Assessment method

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用随机数字表法进行随机分组,随机号装在密封不透光的信封中,由独立研究员进行管理.

Randomization Procedure (please state who generates the random number sequence and by what method):

The random number table method was used for random grouping. The random number was packed in a sealed and opaque envelope and managed by an independent researcher.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

no sharing

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

纸质和电子病例报告表,NoteExpress, Excel

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Paper and electronic case report forms, NoteExpress, Excel

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-03-15 15:31:31